Dr Julene Carvalho is a consultant fetal cardiologist and is head of the Royal Brompton Centre for Fetal Cardiology, where she treats both private and NHS patients.

She graduated with honours in Brazil, and completed her initial training in cardiology in São Paulo.

Following that, she came to London where she completed her training in paediatric cardiology and obtained her PhD.

She subsequently specialised in imaging the fetal heart throughout pregnancy (fetal cardiology) and since 1999, her work has been focused on this area. 

Clinical expertise

Dr Julene Carvalho has extensive experience in imaging the fetal heart and counselling families 'at risk of' or 'affected with' fetal congenital heart disease (CHD).

She pioneered the use of transabdominal fetal echocardiography in the first trimester of pregnancy and is known for her expertise in early scans.

Alongside obstetricians and obstetric ultrasonographers, she works to improve recognition of congenital heart disease before birth, get better results and improve diagnosis.  

Research interests

Dr Julene Carvalho's main research interests relate to fetal arrhythmias (an abnormal rhythm of the fetal heart).

She is the UK chief investigator of a randomised control trial on the treatment of fetal tachycardia, which is part of the National Institute for Health Research (NIHR), clinical research network portfolio.

Other current interests include:

  • the heart in early pregnancy
  • changes in the fetal heart around the time of birth
  • prenatal manifestations of inherited cardiac conditions.


Dr Julene Carvalho is a member of the editorial board of Ultrasound in Obstetrics and Gynaecology - one of the leading international journals in the field.

She has published extensively in peer-reviewed journals.

Dr Carvalho is an honorary senior lecturer at the Imperial College London, National Heart and Lung Institute and the Medical School of St George's Hospital.


Dr Julene Carvalho teaches and trains ultrasonographers and obstetricians on how to image the fetal heart effectively to improve antenatal detection rates of CHD.

She lectures regularly in the UK and overseas, and often performs live scanning sessions at scientific meetings around the world. 

“I understand the position overseas students are in and how challenging it is to learn a different language, culture and systems. I train fellows from countries as diverse as Italy, Turkey, France and Malaysia in fetal and paediatric cardiology.”